Clinical Trials in Houston

Showing 8941-8960 of 17,885 trials

A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors

NCT02442414

The purpose of this study is to determine the maximum tolerated dose of KBP-5209 as a single agent when given orally to adult patients with advanced solid tumors that have progressed despite standard therapy, or where there is no standard therapy.

Advanced Solid Tumors

Sihuan Pharmaceutical Holdings Group Ltd.35 participantsStarted Apr 2015

Indianapolis, Indiana, United States • Houston, Texas, United States • Salt Lake City, Utah, United States

COMPLETEDEARLY Phase 1< 1 mile

Transducer Selection in the Speed and Quality of Image Acquisition in FAST Exams

NCT04333680

The Focused Assessment of Sonography for Trauma (FAST) is a rapid point-of-care ultrasound exam performed on blunt and penetrating trauma patients who are too critically injured to be transported to a CT scanner. Low-frequency ultrasound is used to image the abdomen and pericardium in these patients, using either a curvilinear transducer or a phased-array transducer. Whether the use of one transducer or the other is better for this application is not well studied. In this study, physician ultrasound operators will perform the FAST exam on healthy non-injured volunteers to determine if the speed or quality of images between the two transducer types is different.

Diagnostic Abdominal UltrasonographyTrauma Injury

Baylor College of Medicine31 participantsStarted Feb 2021

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)

NCT02227875

To test whether Mylan's insulin glargine once daily is non-inferior to Lantus® once daily (both administered in combination with other anti-diabetic drugs) based on the change in HbA1c from baseline to 24 weeks

Type 2 Diabetes

Mylan Inc.560 participantsStarted Aug 2014

Chandler, Arizona, United States • Bell Gardens, California, United States • Fresno, California, United States +117 more locations

A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors

Transducer Selection in the Speed and Quality of Image Acquisition in FAST Exams

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)

Find Trials by Condition in Houston

Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer

A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes

Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study)

Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines

Zilver® PTX® V Clinical Study

A Study in Subjects With Advanced Solid Tumors

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)